0
Commentary |

Lessons From Recent Research About the Placebo Effect—From Art to Science

Howard Brody, MD, PhD; Franklin G. Miller, PhD
[+] Author Affiliations

Author Affiliations: Department of Family Medicine, Institute for the Medical Humanities, University of Texas Medical Branch, Galveston (Dr Brody); and Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, Maryland (Dr Miller).


JAMA. 2011;306(23):2612-2613. doi:10.1001/jama.2011.1850
Text Size: A A A
Published online

Medicine has been of 2 minds, so to speak, regarding the placebo effect in clinical practice. On the one hand, the placebo is disparaged as an inert and deceptive intervention intended to please or placate the patient but without any potential to produce meaningful therapeutic benefit. On the other hand, placebo effects are touted as having the power to produce substantial symptomatic relief across a wide range of medical conditions. Until recently, scientific data that elucidate the mechanisms of placebo effects and evaluate their potential to significantly enhance patient care have been lacking. During the past decade, there have been advances in scientific research on the placebo effect, paving the way for evidence-based techniques for promoting placebo responses in clinical practice in ethically appropriate ways.1 Additionally, practitioner surveys indicate that physicians today appear much more comfortable acknowledging the placebo effect as a therapeutic tool consistent with a scientific understanding of the mind-body connection.2 3

Recent research on the placebo effect has been conducted with more methodological rigor than older studies, allowing better discrimination between true placebo responses and confounding variables such as natural variations in symptom severity. For instance, neuroimaging studies have demonstrated some of the pathways activated when study participants receive placebos and then experience therapeutic responses, including release of endogenous opioids and dopamine. Neurophysiology and neurochemistry suggest that there are multiple placebo effects, with different neurobiological mechanisms, depending on the organ system and the target illness.1

Moreover, experimental comparisons of open administration vs hidden administration of analgesic and antianxiety medication (ie, with hidden administration involving the same dose of medication administered by an infusion pump concealed behind a screen) consistently showed a greater effect when patients knew they were receiving the drug compared with the same dosage given by hidden intravenous infusion.4 This suggests that a substantial proportion of symptomatic relief from these drugs was derived from the positive effects of the clinical encounter, which augments their inherent pharmacological properties.

In addition, in a study of patients with irritable bowel syndrome, sham acupuncture treatment administered impersonally resulted in a greater therapeutic response than no treatment, but the addition of a warm interpersonal relationship independently added a substantial therapeutic benefit.5

Two intertwined psychological mechanisms are thought to underlie placebo effects—expectancy and conditioning.1 Positive beliefs about future outcomes, especially when connected with an intervention recommended by a clinician, may trigger those outcomes. Moreover, much of medical practice consists of repeated rituals that may create conditioned responses that can be reactivated in the future by placing the patient in a similar environment. In conscious persons, conditioning overlaps with learning, thus creating positive expectancies. There remains much to be discovered about taking advantage of placebo effects in clinical practice. However, promoting placebo responses no longer falls within the black box of “the art of medicine” but has become amenable to scientific experimentation in service of evidence-based patient care.6

How can the engaged, compassionate practitioner best stimulate placebo effects? The first step is to identify the task as an explicit goal of patient encounters and relationships. Rather than deny medicine's ritual elements as incompatible with or incidental to scientific aspirations, clinicians can capitalize on the common rituals of daily practice. For example, rather than advising the patient to get more exercise, a physician can write a prescription for exercise on a prescription pad, thus using ritual in a way designed to elicit a placebo response along with increased adherence.

Physicians may elicit placebo effects by altering the meaning of the patient's illness experience in a positive direction. Alternatively, by means of conditioning, the physician taps latent meaning that has become associated with past healing events. Good ways to enhance everyday encounters include inviting and listening carefully to the patient's story of illness experience, offering a satisfying explanation for the patient's distress, expressing care and concern, communicating positive expectations for therapeutic benefit, and helping the patient to feel more in control of life in the face of the illness.7 None of these activities need add considerable time to the encounter, because each does double duty. Listening well is a part of good history taking. Explaining the illness and proposing positive ways to deal with illness are part of therapy and patient education, besides contributing to shared decision making. Care and concern can be expressed by the clinician's attitude and demeanor as the other activities are performed.

Although practitioners' interest in promoting placebo effects is heartening, some physicians appear willing to prescribe unnecessary and potentially toxic medications, such as antibiotics and sedatives, for their placebo effects.2 3 Appreciation of mind-body science would reassure physicians that they need not prescribe such placebo treatments to alter the meaning in a way that promotes positive outcomes. But what about low-risk interventions such as acupuncture to treat low back pain? Today, if rigorous clinical trial evidence shows such modalities to be better than no treatment or usual care but no better than placebo, the treatment is often summarily dismissed. An open question for future research and ethical reflection is whether such modalities can be recommended consistent with informed consent.8

Recent research now challenges the prior beliefs that placebo treatments must be prescribed deceptively in order to work.9 This suggests 2 different approaches. Prescribing sugar pills openly as helpful placebos, taking advantage of the ritual of therapy, may be a superior alternative for some patients than a watch-and-wait strategy. Others, however, would argue that there are many other ways to invoke placebo effects via therapeutic rituals and positive communication and relationships. Relying on pharmacologically inert pills, even with patient consent, is largely unnecessary and may merely reinforce deleterious habits of overmedication.

Although patient beliefs vary depending on geography, culture, and education, at least some of today's patients are eager to become active collaborators in mind-body healing practices. Many patients will be relieved to learn that the physician wishes to avoid unnecessary and potentially harmful drugs and wants to maximize the powers of the mind alongside those drugs and other modalities that are well supported by scientific evidence. By sharing with patients the general sorts of techniques that can alter meaning, physicians can empower patients to become their own placebo stimulators. For example, the clinician may ask a patient: “Tell me about the times when you feel that your asthma is really in charge of your life. Then tell me about the times when you feel that you're running your life despite the asthma. Now, let's talk about ways we can help you to do more of those things that make you feel more in charge.” In short, the practitioner has many means to help each person activate the potentially powerful inner pathways that assist healing. Involving the patient in such a dialogue may help to determine whether this patient would do well with a nonpill ritual for stimulating a placebo effect, or whether the patient is so wedded to medications that only the use of an inert-content pill or similar treatment will suffice.

Developments in research on placebos suggest that the time has come to translate the science of placebo effects and knowledge regarding techniques for promoting placebo responses into clinical practice and medical education. This holds promise for bridging the long-standing gap between the scientific and humanistic orientations of modern medicine, with a potentially important pay off in enhancing patient care.

AUTHOR INFORMATION

Corresponding Author: Howard Brody, MD, PhD, Institute for the Medical Humanities, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555 (habrody@utmb.edu).

Conflict of Interest Disclosures: Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

Disclaimer: The opinions expressed herein are those of the authors and do not necessarily reflect the position or policy of the National Institutes of Health, the Public Health Service, or the US Department of Health and Human Services.

Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects.  Lancet. 2010;375(9715):686-695
PubMed
Tilburt JC, Emanuel EJ, Kaptchuk TJ, Curlin FA, Miller FG. Prescribing “placebo treatments”: results of national survey of US internists and rheumatologists.  BMJ. 2008;337a1938
PubMed
Kermen R, Hickner J, Brody H, Hasham I. Family physicians believe the placebo effect is therapeutic but often use real drugs as placebos.  Fam Med. 2010;42(9):636-642
PubMed
Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease.  Lancet Neurol. 2004;3(11):679-684
PubMed
Kaptchuk TJ, Kelley JM, Conboy LA,  et al.  Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome.  BMJ. 2008;336(7651):999-1003
PubMed
Miller FG, Colloca L, Kaptchuk TJ. The placebo effect: illness and interpersonal healing.  Perspect Biol Med. 2009;52(4):518-539
PubMed
Brody H. The placebo response: recent research and implications for family medicine.  J Fam Pract. 2000;49(7):649-654
PubMed
Miller FG, Colloca L. The legitimacy of placebo treatments in clinical practice: evidence and ethics.  Am J Bioeth. 2009;9(12):39-47
PubMed
Kaptchuk TJ, Friedlander E, Kelley JM,  et al.  Placebos without deception: a randomized controlled trial in irritable bowel syndrome.  PLoS One. 2010;5(12):e15591
PubMed

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects.  Lancet. 2010;375(9715):686-695
PubMed
Tilburt JC, Emanuel EJ, Kaptchuk TJ, Curlin FA, Miller FG. Prescribing “placebo treatments”: results of national survey of US internists and rheumatologists.  BMJ. 2008;337a1938
PubMed
Kermen R, Hickner J, Brody H, Hasham I. Family physicians believe the placebo effect is therapeutic but often use real drugs as placebos.  Fam Med. 2010;42(9):636-642
PubMed
Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease.  Lancet Neurol. 2004;3(11):679-684
PubMed
Kaptchuk TJ, Kelley JM, Conboy LA,  et al.  Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome.  BMJ. 2008;336(7651):999-1003
PubMed
Miller FG, Colloca L, Kaptchuk TJ. The placebo effect: illness and interpersonal healing.  Perspect Biol Med. 2009;52(4):518-539
PubMed
Brody H. The placebo response: recent research and implications for family medicine.  J Fam Pract. 2000;49(7):649-654
PubMed
Miller FG, Colloca L. The legitimacy of placebo treatments in clinical practice: evidence and ethics.  Am J Bioeth. 2009;9(12):39-47
PubMed
Kaptchuk TJ, Friedlander E, Kelley JM,  et al.  Placebos without deception: a randomized controlled trial in irritable bowel syndrome.  PLoS One. 2010;5(12):e15591
PubMed
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
JAMAevidence.com